We can't stress this enough: precision in research compounds means precision in results
Disclosure of interest: Kseniia Manysheva: nothing to disclose E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.04 - STROKE COMPLICATIONS P2565 - ESOC25-2282 ASSESSING THE QUALITY OF VTE PROPHYLACTIC DEVICE USAGE FOR STROKE PATIENTS AT LEEDS GENERAL INFIRMARY: AN AUDIT AND RE-AUDIT Rohid Zamani 1,2 , Daniel McWilliams 1 , Sameer Limaye 1 1 Leeds General Infirmary, Leeds Teaching Hospitals National Health Service Trust, Leeds, United Kingdom, 2 George Eliot Hospital, Nuneaton, United Kingdom Background and Aims: Intermittent pneumatic compression devices (IPCs) and geko devices are used to reduce the risk of VTE in patients who have suffered an acute stroke
Consistency leads to noticeable improvements in energy, mood, and immunity within a few weeks
Moving from mechanistic observations to clinical implementation will require a structured translational roadmap: Methodological Standardization: Standardizing microbiome sampling, sequencing platforms (transitioning from 16S rRNA to high-resolution shotgun metagenomics), and bioinformatic pipelines to improve reproducibility across international cohorts
